Albuquerque, NM, United States of America

Terrance J Scallen

This inventor holds 2 USPTO granted patents. Top assignee: The University of New Mexico. Active years: 1997-2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Terrance J Scallen. Retrieved from https://idiyas.com/inventor/terrance-j-scallen

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1997-2000

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Terrance J Scallen

Introduction

Terrance J Scallen is a notable inventor based in Albuquerque, NM (US). He has made significant contributions to the field of anti-tumor research. With a total of 2 patents, his work has garnered attention in the scientific community.

Latest Patents

Terrance's latest patents focus on the compound .beta.-alethine, which has been identified as an anti-tumor agent. This innovative approach to cancer treatment highlights the potential of .beta.-alethine in combating tumor growth.

Career Highlights

Terrance J Scallen is affiliated with the University of New Mexico, where he conducts his research. His work has been instrumental in advancing the understanding of anti-tumor agents and their applications in medicine.

Collaborations

Some of his notable coworkers include Galen D Knight and Paul L Mann. Their collaborative efforts contribute to the ongoing research and development in the field of oncology.

Conclusion

Terrance J Scallen's contributions to anti-tumor research through his patents and collaborations reflect his dedication to innovation in medicine. His work continues to inspire advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…